←
Luis Pareras MD, PhD513 posts
Luis Pareras MD, PhD avatar

Luis Pareras MD, PhD

@pareras

Founder & Managing Partner at Invivo Capital - Healthequity, Venture Capital investor in life sciences. PhD, neurosurgeon, Global Executive MBA (IESE). I paint.

◷ Joined July 2009▧ 223 Photos and videos
Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·8 Jan 2025

PORTFOLIO NEWS/ I’m proud to announce the first investment from our new fund, Invivo Ventures III. Neumirna Tx has secured a €20M Series A, led by Invivo Partners and Angelini Ventures (corporate arm of Angelini Pharma), to develop RNA-based therapies for drug-resistant epilepsy

Post attachmentPost attachment
Laura Rodríguez avatar
⟳ Luis Pareras MD, PhD retweeted
Laura Rodríguez@laurg87·10 Sep 2024

Engaging discussion on challenges, trends, and value drivers shaping the C&GT space, and the potential growth opportunities in Europe at #ATE24 At @InvivoPartners , we believe the C&GT field will advance into new indications, novel cell types, and cutting-edge technologies.

Post attachment
Menendez Lab avatar
⟳ Luis Pareras MD, PhD retweeted
Menendez Lab@Menendez_Lab·4 Sep 2024

Lovely summary by Drs Luis Pareras and Cinta Díez at @InvivoPartners in interesting strategies to bypass T cell dysfunction!!! Just amplifying their ideas/concepts of interest!!!

Post attachment
Startup Archive avatar
⟳ Luis Pareras MD, PhD retweeted
Startup Archive@StartupArchive_·26 Jul 2024

Sam Altman: “Hire for values first, aptitude second, and skills third.” Most executive recruiters, Sam argues, will reverse this order: “If you say I need to hire a CFO, they will bring you people with 20 years of experience as a CFO at vaguely similar companies. But unfortunately, it’s usually like 20 years of the exact same year of experience over and over again.” But if you’re trying to scale fast, values are most important: “You really need someone who is aligned with the values of the company so that when things change or when they have to make a decision, they’ll make the one you would make if you can’t be there or they will be a good team player and go do that thing.” Sam continues: “You need someone who has high aptitude because the role is going to constantly shift. And the rate of learning - the rate of improvement - dominates skills.” And then skills obviously matter, but for Sam it’s third on the list: “The very best companies take this exceptionally far in how much they’re willing to hire a non-traditionally qualified executive.” Video Source: @ycombinator

0:58
Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·3 Jun 2024

PODCAST/ Here’s my conversation with Christian @Soschner where we talk about AI, Synbio, Art, and the Future of Mankind. Below is the original post from Christian with the full video (a little over 2 hours). CLICK HERE TO WATCH THE EPISODE: lnkd.in/e6_74SgK

Post attachment
Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

10. Energy, not compute, will become the primary bottleneck: A gigawatt—akin to running a nuclear plant dedicated solely to training—hasn't been attempted.

Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

9. A New Kind of Science: Unprecedented progress in fields such as quantum mechanics, astronomy, energy, physics, etc., is being driven by AI's application in solving complex scientific problems (would solving the Riemann hypothesis be a valid test of true creative intelligence?)

Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

8. Understanding Emergence: Exploring how consciousness arises from complexity helps explain why AI is so effective at replicating human intelligence.

Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

7. Safety: As we race towards breakthroughs, red teaming and stringent regulatory oversight are essential to navigate the risks, especially in AI and synbio. The race to AGI brings an economic incentive and a prisoner's dilemma scenario

Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

6. Ethics: The field is rife with ethical dilemmas, from how to deal with fake news and societal changes due to employment disruption, to the ethics of dealing with new intelligences with rights.

Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

5. Physical Intelligence & Robotics: Embodied LLMs in robots are poised to be the next major market sensation. This field will explode, much like smartphones did, with potential sales reaching billions as robotics become ubiquitous.

Luis Pareras MD, PhD avatar
Luis Pareras MD, PhD@pareras·23 Apr 2024

4. Synbio fusion with AI: No synbio company will thrive without AI. Both will enable the creation of new metabolic pathways & designed cells capable of performing functions beyond our imagination.